Last updated: February 5, 2024
Sponsor: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Overall Status: Active - Recruiting
Phase
N/A
Condition
Lung Injury
Acute Respiratory Distress Syndrome (Ards)
Respiratory Failure
Treatment
Invasive Ventilation
Oxygen Therapy
Non-Invasive Ventilation (NIV)
Clinical Study ID
NCT06257784
ASO.RianGen.22.01
Ages 18-110 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Any Acute Respiratory Failure
- SaO2 <92% on air room at ED admission
Exclusion
Exclusion Criteria:
- Age < 18 yo
- Patients already in NIV AND HCFN in ED
- Home-oxygen or Home-NIV therapy
- SpO2 < 80%
- Severe dyspnea
- unable to speak complete sentences
- Uncooperative patients
- Hemodynamic Instability < 90 mmHg or vasopressor requirement at admission
- ST Elevation-Miocardial Infarction
- Tracheo -stomized or -tomized patients
- End of life
Study Design
Total Participants: 600
Treatment Group(s): 3
Primary Treatment: Invasive Ventilation
Phase:
Study Start date:
March 30, 2022
Estimated Completion Date:
March 31, 2024
Study Description
Connect with a study center
Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo
Alessandria, Piedmont 15121
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.